JJ Bienaimé, departing BioMarin CEO
November 1, 2023 05:46 PM EDTUpdated November 2, 09:01 AM
People

JJ Bi­en­aimé is mov­ing out of the C-suite af­ter an 18-year run at Bio­Marin. And you like­ly know his suc­ces­sor

John Carroll

Editor & Founder

Feisty, stub­born Jean-Jacques Bi­en­aimé is step­ping down from the top post at Bio­Marin af­ter an 18-year run with a string of high­lights in 2023. And …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times